Outcome of Board Meeting held on 11th December, 2025 for approval of unaudited (Consolidated and Standalone) financial results for the quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.0 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indrayani Biotech's Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY26 (ended September 30, 2025), with statutory auditors Venkatesh & Co issuing an unmodified limited review opinion. On a consolidated basis, total income grew about 25% YoY in Q2 to Rs. 3,774.98 lakhs (vs Rs. 3,015.99 lakhs), and the company swung back to a profit after tax of Rs. 105.61 lakhs from a loss of Rs. 55.69 lakhs in Q2 FY25. However, consolidated operating cash flow for H1 FY26 was deeply negative at Rs. -1,017.20 lakhs, and total borrowings rose to around Rs. 14,632 lakhs against equity of Rs. 10,382 lakhs. Non-executive Director Ms. Lakshmiprabha Kasiraman resigned effective November 13, 2025 due to personal reasons, prompting reconstitution of the Nomination & Remuneration and Stakeholders Relationship Committees. The Board also acknowledged and paid a Rs. 16,520 fine (including GST) levied by BSE for delayed appointment of a qualified Company Secretary under Regulation 6(1), which has since been complied with.
The sharp YoY revenue growth and return to profitability on a consolidated basis are positives for shareholders, but the large negative operating cash flow and rising debt levels signal working capital stress and continued dependence on borrowings. The governance-related fine and the departure of a director are minor negatives, though the committees have been reconstituted and the compliance issue resolved.